Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Clinical trial NCT03356860 · COMPLETED
Trial details
- NCT number
- NCT03356860
- Sponsor
- Grand Hôpital de Charleroi
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-13
- Primary completion
- 2022-11-21
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.